Zobrazeno 1 - 10
of 10
pro vyhledávání: '"N I, Belyanchikova"'
Publikováno v:
Bulletin of Experimental Biology and Medicine. 85:372-375
Hemangiopericytoma growth in syngeneic male mice F1 (CBA X C57BL/bj) led to regular hemopoietic changes: an increase in the spleen weight, spleen cell count, in the number of colony-forming units (CFU). It also induced augmentation of myelopoiesis in
Publikováno v:
Bulletin of Experimental Biology and Medicine. 92:1418-1421
Relations between the malignant tumor and host organism are characterized, on the one hand, by rapid division of the tumor cells, liberation of metabolic and breakdown products into the blood stream, the spread of the cells through the body, their in
Publikováno v:
Bulletin of Experimental Biology and Medicine. 93:804-807
Publikováno v:
Pharmaceutical Chemistry Journal. 21:461-463
Autor:
M. A. Volkova, Yu. E. Vinogradova, V. I. Trubitsina, V. D. Nikitin, Slavina Eg, D. M. Mkheidze, L. F. Morozova, S. A. Galetskii, A. Yu. Baryshnikov, A. V. Glazunov, G. Ya. Svet-Moldavskii, T. M. Polotskaya, R. M. Radzikhovskaya, V. A. Kutimov, N. I. Belyanchikova
Publikováno v:
Bulletin of Experimental Biology and Medicine. 83:853-855
An antimyeloblastic immune serum (AMS) was prepared by immunizing horses with white blood cells (WBC) from a patient with chronic myeloid leukemia (CML) in the blast crisis stage. The serum was exhausted in relation to antibodies against red and whit
Autor:
E. R. Vasil'eva, R. M. Radzikhovskaya, Yu. E. Vinogradova, V. G. Markaryan, L. F. Morozova, A. Yu. Baryshnikov, M. A. Volkova, T. M. Polotskaya, I. V. Frenovskaya, N. I. Belyanchikova
Publikováno v:
Bulletin of Experimental Biology and Medicine. 87:604-606
The presence of a common antigen on B lymphocytes of healthy blood donors and on myeloblasts of patients with chronic myeloid leukemia (CML) in the blast crisis (BC) stage was established with the aid of an antimyeloblast serum by the indirect surfac
Publikováno v:
Bulletin of Experimental Biology and Medicine. 91:83-85
Autor:
George J. Svet-Moldavsky, V. M. Buchman, T. A. Litovchenko, D. M. Mkheidze, N. I. Belyanchikova, M. F. Barkhotkina, M. R. Lichinitser
Publikováno v:
Cancer Chemotherapy and Pharmacology. 3
Normal mice and mice with advanced leukemia were injected IP with cytosine arabinoside (araC) on a lethal treatment schedule. The simultaneous oral administration of deoxycytidine (CdR) in dose 2–3 times as high as those of araC prevented drug-rela
Autor:
A J, Baryshnikov, R M, Radzikhovskaya, L F, Morozova, N I, Belyanchikova, E G, Slavina, J E, Vinogradova, D M, Mkheidze, T M, Polotskaya, M A, Volkova, G J, Svet-Moldavsky, V D, Nikitin, V A, Kutimov, V I, Trubitsina, S A, Goletsky, A, Glazunov
Publikováno v:
Biomedicine / [publiee pour l'A.A.I.C.I.G.]. 25(9)
The antiserum was obtained from horses immunized with cells from patients with blastic crisis of CML and completely absorbed with normal white blood cells (WBC). The absorbed antiserum remained cytotoxic to blast cells from nearly half of the patient
Autor:
N. I. Belyanchikova
Publikováno v:
Bulletin of Experimental Biology and Medicine. 63:395-396